# Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

> **NCT00141401** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 240 (—)

## Conditions studied

- Diabetic Neuropathy, Painful

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT00141401
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 240 (—)
- **Last updated:** 2007-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141401, "Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00141401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*